BioTransform
2021-04-21
09:55 - 10:00
Opening Remarks
Opening Remarks image
Lindsay Smart
Managing Director, Zeta USA inc
10:00 - 10:20
“Infinite opportunities from infinite data; maximising potential in medicines development and manufacturing”
“Infinite opportunities from infinite data; maximising potential in medicines development and manufacturing” image
Siobhan Fleming
Collaborations Manager, Siemens
10:20 - 10:40
IoT and Digitalization in Pharma, Trends Experiences and Learnings
IoT and Digitalization in Pharma, Trends Experiences and Learnings image
Rene Zoelfl
Business Development Director, PTC
10:40 - 11:30
Panel Discussion : IoT and Digitalization: Current Experiences and Future Trends in Biopharma
Panel Discussion : IoT and Digitalization: Current Experiences and Future Trends in Biopharma image
Martin Mayer
Business Development Smart Engineering Services & Digitalization - ZETA
Panel Discussion : IoT and Digitalization: Current Experiences and Future Trends in Biopharma image
Rene Zoelfl
Business Development Director, PTC
Panel Discussion : IoT and Digitalization: Current Experiences and Future Trends in Biopharma image
Siobhan Fleming
Collaborations Manager, Siemens
Panel Discussion : IoT and Digitalization: Current Experiences and Future Trends in Biopharma image
Ian Pepper
IoT Lead, Novartis
11:30 - 11:40
Coffee Break & Networking
11:40 - 12:00
The journey towards Manufacturing Digital Twin
The journey towards Manufacturing Digital Twin image
Adam O’Toole
Domain Architect – Manufacturing & Engineering, Novartis
12:00 - 12:20
Strategies for Generation and Adaptation of Digital Twins: Some Hybrid Modeling Success Stories
Strategies for Generation and Adaptation of Digital Twins: Some Hybrid Modeling Success Stories image
Mark Dürkop
Founder & CEO, Novasign
12:20 - 12:40
Manufacturing Digitalization and Its Implications for Policymakers
Manufacturing Digitalization and Its Implications for Policymakers image
Stephen Ezell
Vice President, Global Innovation Policy | The Information Technology & Innovation Foundation
12:40 - 13:00
Human Amniotic Fluid Stem Cells for Regenerative Medicine
Human Amniotic Fluid Stem Cells for Regenerative Medicine image
Dr.Bruce Young
Founder Amnicell
13:00 - 13:10
Lunch Break & Networking
13:10 - 13:30
Single Use Technology
Single Use Technology image
Jeff Johnson
President - Biotech Design LLC
13:30 - 14:20
Panel Discussion : Challenges & Opportunities Gene Therapy Manufacturing With Single-Use Technology
Panel Discussion :  Challenges & Opportunities Gene Therapy Manufacturing With Single-Use Technology image
Jeff Johnson
President - Biotech Design LLC
Panel Discussion :  Challenges & Opportunities Gene Therapy Manufacturing With Single-Use Technology image
Dr Nina Bauer
Head of Commercial for the Gene Editing and Novel Modalities Business - Merck KGaA
Panel Discussion :  Challenges & Opportunities Gene Therapy Manufacturing With Single-Use Technology image
Eric Halioua
President & CEO PDC Line Pharma
Panel Discussion :  Challenges & Opportunities Gene Therapy Manufacturing With Single-Use Technology image
Robert Lechich
Principal Manufacturing and Supply Chain Consultant at Global OT/IT
14:20 - 14:40
ATMP Data Management: First Step towards Digital Transformation
ATMP Data Management: First Step towards Digital Transformation image
Robert Lechich
Principal Manufacturing and Supply Chain Consultant at Global OT/IT
14:40 - 15:30
Outlook on USA BioPharma sector
Outlook on USA BioPharma sector image
Stephen Ezell
Vice President, Global Innovation Policy | The Information Technology & Innovation Foundation
Outlook on USA BioPharma sector image
Chris Garabedian
Chairman and CEO, Xontogeny LLC
Outlook on USA BioPharma sector image
Matthew Kunicki
Senior Scientist, Pfizer
Outlook on USA BioPharma sector image
Chor Sing Tan
Strategic Manager, Cytiva
15:30 - 15:35
Closing Remarks
Closing Remarks image
Lindsay Smart
Managing Director, Zeta USA inc
Select date to see events.